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SUMMARY
Objective: To investigate the MTHFD1 G1958A polymorphism involved in the folate 
metabolism as a risk for head and neck cancer, and to find the association of the poly-
morphism with the risk factors and clinical and histopathological characteristics. Metho-
ds: Retrospective study investigating MTHFD1 G1958A polymorphism in 694 subjects 
(240 patients in the Case Group and 454 in the Control Group) by Restriction Fragment 
Length Polymorphism (RFLP) Analysis. Multiple logistic regression and chi-square tests 
were used in the statistical analysis. Results: Multivariable analysis showed that smoking 
and age over 42 years were disease predictors (p < 0.05). MTHFD1 1958GA or AA geno-
types were associated with smoking (p = 0.04) and alcoholism (p = 0.03) and were more 
often found in more advanced stage tumors (p = 0.04) and in patients with a shorter 
survival (p = 0.03). Conclusion: The presence of MTHFD1 G1948A polymorphism as-
sociated with smoking and alcoholism raises the head and neck cancer risk. 
Keywords: Polymorphism, genetic; head and neck neoplasms; alcoholism; smoking; me-
thylenetetrahydrofolate dehydrogenase (NADP). 
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INTRODUCTION
Head and neck neoplasms account for high incidence of 
deaths worldwide, being considered the sixth most common 
type1. The anatomical areas aected by these tumors include 
the oral cavity (40%), the pharynx (15%) and the larynx 
(25%)2. Data from the National Cancer Institute2 showed 
there is a 3:1 male-female ratio and a higher incidence of 
oral cavity-located cases in the Brazilian population.
Head and neck cancer has smoking and alcoholism as its 
main risk factors1. Viral infections, especially with Epstein-
Barr virus and human papillomavirus (HPV) subtypes 16 
and 18, in addition to deficiencies or imbalances of vitamins 
and micronutrients, such as folic acid, vitamins A, C and E, 
zinc and selenium, were also associated with head and 
neck neoplasms occurrence3-5.
Folate has a key role in oncology, mainly from its ac-
tion on DNA methylation and purine and pyrimidine 
synthesis6. Genetic changes and deficiency of this vitamin 
show a relationship with cancer in several studies, includ-
ing head and neck cancer6-15.
The Methylenetetrahydrofolate dehydrogenase 1 
(MTHFD1) gene is responsible for the generation of 
10-formyl-THF, which is essential for DNA synthesis. 
There is a polymorphism at the nucleotide 1958 (G®A), 
resulting in an substitution of alanine for glycine at the co-
don 653, located at the domain 10-formyl-THF synthase of 
the enzyme16. If folate availability is continuously limited, 
an uncontrolled repair cycle can cause frequent breaks in 
DNA molecule and chromosome damage, resulting in ma-
lignant cell change, contributing to cancer development6.
Few studies investigated this polymorphism in cancer 
and the results are inconsistent. Kruszyna et al.17 did not 
find any significant statistical dierences in genotype and 
allele frequency of MTHFD1 A1958G polymorphism in 
patients with larynx cancer. Matakidou et al.18 and Chen 
et al.19 did not associate the same polymorphism with lung 
and colorectal neoplasms, respectively. On the other hand, 
Li et al.20 found no association of MTHFD1 G1958A poly-
morphism with breast cancer.
Thus, the objectives of this study were to investigate 
MTHFD1 G1958A polymorphism involved in folate me-
tabolism on head and neck cancer risk and the association 
between this polymorphism with risk factors (tobacco and 
alcohol comsumption) and clinical histopathological char-
acteristics (primary site, lymph node involvement, and tu-
mor extension).
METHODS
This study sample consisted of 694 subjects, 240 patients 
with head and neck cancer (case group) and 454 subjects 
with no neoplasms history (control group) after obtaining 
the informed consent (Opinion 5566/2005, Ethics in Re-
search Committee – CEP – Medicine School of São José do 
Rio Preto – FAMERP).
The patients were included in the study after a histopath-
ological diagnosis of squamous cell carcinoma by the Ser-
vice of Otorhinolaryngology and Head and Neck Surgery 
at Hospital de Base, São José do Rio Preto/SP. The tumors 
were classified according to the 2002 International Union 
of Cancer Control (IUCC) and the 2002 American Joint 
Committee for Cancer (AJCC) parameters into three crite-
ria: tumor size (T), presence of regional node involvement 
(N) and presence of distant metastasis (M). By considering 
the anatomical location, they were classified as oral cavity, 
pharynx, larynx and unknown primary site tumors21,22. The 
blood sample DNA was obtained from the laboratory sam-
ple bank, collected from March 2000 to October 2009.
The control group consisted of 454 Brazilian blood do-
nors without a diagnosis of cancer according to government 
guidelines for donated blood that is tested for 20 related dis-
eases (http://www.hemonline.com.br/rdc153/indexframe.
htm). The inclusion and exclusion criteria were, respective-
ly, age over 40 and history of family neoplasm. Each eligible 
subject was interviewed to obtain data on gender, smoking 
habit, use of alcohol, and family history of cancer. Individu-
als who had smoked more than 100 cigarettes in their life-
time were considered to be tobacco consumers and individ-
uals who drank 4 doses of alcohol per week were considered 
to be alcohol consumers23,24.
Genomic DNA was obtained from peripheral blood 
for molecular analysis according to the modified Miller et 
al.25 technique. Polymerase Chain Reaction – Restriction 
Fragment Length Polymorphism (PCR-RFLP) analysis was 
used to determine the MTHFD1 G1958A polymorphism 
genotypes. The primers used were described by Holftet al.26 
(Sense: 5’ft–ftCACTCCAGTGTTTGTCCATGft–ft3’; Anti-
sense: 5’ft–ftGCATCTTGAGAGCCCTGACft–ft3’). Amplifi-
cation was obtained by initial denaturation at 95°C (203°F) 
for 5 minutes, followed by 35 cycles of 30-second for DNA 
denaturation at 95°C (203°F), 50-second primer annealing 
at 53°C (127°F) and 90-second extension at 72°C (161°F). 
The final extension was conducted for 5 minutes at 72°C 
(161°F). The product of 331bp underwent enzymatic diges-
tion by the enzyme MspI for 3 hours at 37°C (98°F). Frag-
ments of 166ftbp and 70ftbp were generated when the G allele 
was present, and the fragment with 266ftbp was generated 
when the A allele was present.
The statistical analysis was conducted by using the 
software Minitab/Windows – Version 14.0 to assess the 
eftects of the variables analyzed in head and neck cancer, 
and Bio Estat version 3.0 to ascertain if enotypic distribu-
tions were in Hardy-Weinberg equilibrium. The multiple 
logistic regression test was used to determine the eftect of 
variables analyzed in head and neck cancer, including age 
(reference: <ft42 years – age in quartiles), gender (refer-
ence: female), tobacco consumption status (reference: non-
smokers), alcohol consumption (reference: non-alcoholics) 
and also to analyze clinical and histopathological variables. 
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The T classification was divided into small extension tu-
mors (T1, T2) and large extension tumors (T3, T4). The 
N classification was dichotomized into negative node 
involvement (N0) and positive node involvement (N1, 
N2, N3). The results were shown as odds ratio (OR) and 
95% confidence interval (95%CI). The significance level 
was set at 5% (p0.05). The Kaplan-Meier method was 
applied to evaluate the survival rate, by considering the 
period between the disease diagnosis and the death as 
end point.
RESULTS
The results of multiple logistic regression test between 
groups showed significant dierences between cases and 
controls regarding to tobacco consumption and age over 
42 years (p < 0.05) and, therefore, were predictors of the 
disease (Table1).
The Hardy-Weinberg test showed the genotypic dis-
tribution was in equilibrium in the study sample (case: 
c2=0.7096; p=0.3996; control: c2=0.0707; p=0.7903). 
MTHFD1 G1958A polymorphism was not associated 
with the disease risk. The genotypic frequencies MTH-
GD1 1958GG, GA and AA were 35.83%, 45.83% and 
18.34%, respectively, for the cases and 35.46%, 48.68% 
and 15.86%, respectively, for controls. The variant 
MTHFD1 1958G allele frequencies were 0.59 among the 
cases and 0.6 among the controls, while the MTHFD1 
1958A allele frequencies were 0.41 and 0.4 among cases 
and controls, respectively.
The multiple logistic regression test results for the 
interaction between risk factors and MTHFD1 G1958A 
polymorphism showed that tobacco consumption 
(OR: 1.68; 95%CI: 1.01-2.78; p=0.46) and alcohol 
consumption(OR: 1.83; 95%CI: 1.06-3.15; p=0.03) asso-
ciated with MTHFD1 1958GA or AA genotype raised the 
risk of development of head and neck cancer (Table2).
Regarding clinical and histopathological param-
eters, the results of the multiple logistic regression test 
showed association of polymorphism with tumor stag-
ing, being MTHFD1 1958GA or AA genotypes more 
frequent in stage 3 and 4 cases (p = 0.04) (Table3).
The overall survival rate obtained by Kaplan-
Meier estimates, was 82.57 months for patients with 
MTHFD1 1958GG genotype and 59.03 for patients with 
MTHFD1 1958GA or AA genotype, as shown in Fig-
ure1 (p=0.031).
DISCUSSION
The results showed that smoking and age over 42 years 
were predictors for head and neck cancer, corroborating to 
literature data, confirming this neoplasia is more frequent 
from the fourth decade of life27 and in smokers28-32.
Folate acts as a coenzyme in several cell reactions, be-
ing required in cell division because of its role in purine 
and pyrimidine biosynthesis and consequently in DNA and 
RNA formation33.
The MTHFD1 gene is involved in folate metabolism 
and codes for a cytosolic protein comprising 5,10-meth-
ylene-THF dehydrogenase, 5,10-methenyl-THF cyclo-
hydrolase and 10-formyl-THS synthase. The enzymes 
methylene-THF dehydrogenase and methenyl-THF 
cyclohydrogenase, located at the same protein do-
main, catalyze the oxidation of 5,10-methylene-THF to 
5,10-methenyl-THF, converted to 10-formyl-THF. 
Table 1 – Demographic distribution, risk factors, genotypes and odds ratio (OR) for head and neck cancer
Variables Case group (%) Control group (%) OR (95%CI) p value
Tobacco consumption
Non-smokers 41 (17.08) 267 (58.81) Reference Reference
Smokers 199 (82.92) 187 (41.19) 3.90 (2.46-6.20) p < 0.05
Alcohol consumption
Non-alcoholics 67 (27.92) 230 (50.66) Reference Reference
Alcoholics 173 (72.08) 224 (49.34) 1.56 (0.99-2.48) p  = 0.056
Gender
Female 29 (12.08) 129 (28.41) Reference Reference
Male 211 (87.92) 325 (71.59) 1.65 (0.95-2.86) p  = 0.073
Age
<42 years 8 (3.33) 177 (38.99) Reference Reference
42-51 years 49 (20.42) 170 (37.44) 5.22 (2.53-10.77) p < 0.05
52-63 years 99 (41.25) 51 (11.23) 28.75 (13.51-61.18) p  < 0.05
>64 years 84 (35) 56 (12.34) 24.51 (11.57-51.92) p  < 0.05
MTHFD1 G1958A genotype
GG 86 (35.83) 161 (35.46) Reference Reference
GA 110 (45.84) 221 (48.68)
1.38 (0.91-2.10) p  = 0.135
AA 44 (18.33) 72 (15.86)
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These three sequential reactions are involved in the in-
terconversion of THF carbon-1 derivatives, which are 
substrates for methionine, thymidylate and purine syn-
thesis19,34. The G1950A polymorphism in this gene can 
be associated with cancer due to DNA synthesis changes 
and consequent lack of cell controll20.
In the current study, a balanced genotypic distribution 
was observed, corroborating to Kruszyna et al.17 study, which 
did not find significant statistical difterences in MTHFD1 
A1958G polymorphism genotype and allele frequency.
In our study, MTHFD1 G1958A polymorphism was 
not associated with head and neck cancer risk, similarly to 
Kruszyna et al.17 findings in 131 patients with larynx can-
cer and 250 control patients, Matakidou et al.18 findings in 
619 patients with lung cancer, and Chen et al.19 findings 
in 274 patients with colorectal cancer and 461 controls.
However, Li et al.20, investigating 227 patients, showed 
MTHFD1 1958AA polymorphic genotype occurred more 
often in patients with breast cancer than MTHFD1 1958GG 
wild genotype. In the same study, the association between 
higher methylation frequency in patients with breast cancer 
and MTHFD1 1958AA polymorphic genotype was found.
In our study, there was a significant association be-
tween MTHFD1 1958GA or AA genotypes and tobacco 
and alcohol consumption, suggesting that individuals with 
these habits and GA or AA genotypes have a higher inci-
dence of head and neck cancer. No available literature data 
prove this association.
Variables
GG genotype 
cases/control
OR (95%CI)
GA and AA genotypes 
cases/control
OR (95%CI)* p value
Age
< 42 years 4/53 1.00 (ref) 6/123 0.38 (0.09-1.50) p = 0.166
42-51 years 19/64 1.00 (ref) 36/105 1.78 (0.83-3.80) p = 0.136
52-63 years 31/19 1.00 (ref) 60/32 2.02 (0.86-4.79) p = 0.108
> 64 years 30/22 1.00 (ref) 54/34 1.31 (0.60-2.83) p = 0.496
Gender
Female 10/42 1.00 (ref) 19/87 1.41(0.50-3.96) p = 0.519
Male 76/135 1.00 (ref) 119/206 1.37 (0.85-2.19) p = 0.192
Smoking consumption
No 23/97 1.00 (ref) 18/170 0.98 (0.45-2.14) p =  0.964
Yes 63/64 1.00 (ref) 136/123 1.68 (1.01-2.78) p = 0.046
Alcohol consumption
No 29/77 1.00 (ref) 38/153 0.95 (0.49-1.85) p = 0.890
Yes 57/84 1.00 (ref) 116/140 1.83 (1.06-3.15) p = 0.030
Table 2 – Distribution of risk factors related to head and neck cancer and MTHFD1 G1958A polymorphism
Clinical parameters
GG genotype 
cases (%)
OR 95%CI)
GA and AA  
genotypes cases (%)
OR (95%CI)* p value
Primary Site
Oral cavity 35 (14.58) 1.00 (ref) 61 (25.42) 0.88 (0.51-1.53)  p = 0.659
Pharynx 15 (6.25) 1.00 (ref) 36 (15) 1.42 (0.72-2.81)  p = 0.312
Larynx 28 (11.67) 1.00 (ref) 45 (18.75) 0.80 (0.45-1.43) p = 0.454
Tumor size
T1/T2 47 (19.58) 1.00 (ref) 107 (44.58) 1.00 (ref)
T3/T4 37 (15.42) 1.00 (ref) 49 (20.42) 0.57 (0.32-0.98) p = 0.044
Lymph node involvement
No 58 (24.17) 1.00 (ref) 111 (46.25) 1.00 (ref)
Yes 26 (10.83) 1.00 (ref) 45 (18.75) 0.90 (0.50-1.62) p = 0.721
Table 3 – Distribution of clinical and histopathological parameters and MTHFD1 G1958A polymorphism
Figure 1 – Nonparametric survival plot (Kaplan-Meier) of 
patients with head and neck squamous cell carcinoma.
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The analysis of clinical and histopathological parame-
ters confirmed T3 and T4 tumors (advanced tumors) had 
a higher frequency in patients with GA or AA genotypes. 
The study by Kruszyna et al.17, analyzing the genotype 
significance for tumor characteristics, showed a weak 
association between MTHFD1 genotypes and the tu-
mor size.
The overall survival rate obtained by Kaplan-Meier 
estimate, showed the patients with MTHFD1 1958GG 
wild genotype had a higher mean survival compared to 
patients with MTHFD1 1958GA or AA genotypes (at 
least one polymorphic allele), confirming an association 
between the polymorphic allele presence and the reduced 
mean survival time. According to a bibliographic survey, 
this is the first study investigating the association be-
tween survival time and the polymorphism presence.
CONCLUSION
Smoking and age over 42 years modulate head and neck 
cancer, regardless the genetic variable. The presence of 
MTHFD1 G1958A polymorphism associated with to-
bacco and alcohol consumption increases of head and 
neck cancer risk. The polymorphism is more frequent 
in more advanced stage tumors and in patients with 
a poorer prognosis. It is important to corroborate by 
studies the influence of MTHFD1 gene polymorphism, 
as well as the influence of polymorphisms in other genes 
involved in folate metabolism on head and neck cancer 
genesis, so that the etiology and the significant correla-
tions with clinical and histopathological characteristics 
of these tumors can be determined.
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